Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each),...

FDA Recall #D-0141-2026 — Class III — October 10, 2025

Recall #D-0141-2026 Date: October 10, 2025 Classification: Class III Status: Ongoing

Product Description

Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Recalling Firm

Endo USA, Inc. — Malvern, PA

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

935 cartons

Distribution

Nationwide within the United States

Code Information

Lot #: 550162801, Exp. Date NOV-25; 550169801, Exp. Date JAN-26

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated